From January 1, 2024 to March 31, 2024, the company has repurchased 166,508 shares, representing 0.83% for CAD 0.08 million. With this, the company has completed the repurchase of 885,711 shares, representing 4.36% for CAD 0.47 million under the buyback announced on August 29, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 CAD | 0.00% |
|
+3.61% | -12.24% |
08/05 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
08/05 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
1st Jan change | Capi. | |
---|---|---|
-12.24% | 6.08M | |
+41.74% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.72% | 246B | |
+0.25% | 225B | |
+10.42% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.